Rocket Lab USA, Inc. (NASDAQ: RKLB) shares climbed about 4% in Tuesday trading, changing hands near $75.70, after Bloomberg reported that NASA is preparing a bulk purchase of rocket launches to support its $30 billion moon base program.

Carlos García-Galán, NASA's moon base program manager, told Bloomberg that the agency will “probably announce the first set of these bulk buys” soon. Under the plan taking shape, NASA could order four or five different rocket types in a single batch and then assign each launch vehicle to a commercial lunar lander. The agency also indicated that any leftover launch capacity could be made available to other government agencies. A batch award structured that way would put several launch companies on a single government procurement at once, rather than concentrating the work with one provider.

The report's timing coincides with World Space Week, which began on October 4 across 100 countries. This year's theme is “Rocket Revolution,” and organizers point to falling launch costs as a key driver of new activity across the space sector.

A Falcon 9 Booking Freeze Opens the Door

A larger shift is playing out behind the NASA news. SpaceX has started turning away satellite operators who want dedicated Falcon 9 launches after 2028, declining new bookings for that period. The Falcon 9 has ranked among the most frequently flown rockets in the industry, and its tightening availability has created a gap that a wave of newer vehicles is now positioning to fill.

Rocket Lab's Neutron, the company's larger launch vehicle in development, is one of the candidates lining up, alongside Relativity Space's Terran R, Firefly Aerospace's Eclipse, and Stoke Space's Nova. None of these rockets has yet proven it can fly at high volume. Building up launch cadence takes years, so it is not guaranteed that any of them will be flying regularly by 2029. NASA's first bulk-buy announcement, which García-Galán suggested is coming soon, will provide the first concrete checkpoint for these vehicles.

Rocket Lab's business, however, is not solely tied to Neutron. The company also builds the Electron rocket, manufactures Photon satellite platforms, and runs full missions for both government and commercial customers, spanning launch services as well as spacecraft hardware. The hardware side of that business also sits apart from the launch squeeze: satellites need solar cells, structures, and star trackers no matter which rocket carries them to orbit.

The Numbers Behind the Rally

Tuesday's advance adds to a solid run for RKLB. The stock is up 13.6% over the past month, while the Zacks Aerospace-Defense Equipment industry has dropped 5% over the same period. Peers have not kept pace: Curtiss-Wright fell 4.6% and TransDigm dropped 6% during that span.

Rocket Lab's growth is coming largely from its Space Systems segment, which produces solar cells, composite structures, star trackers, batteries, and other spacecraft components. In Q2 2026, total revenue rose 62% year over year to $234.1 million. Space Systems revenue alone jumped 94% to $189.5 million, helped by acquisitions and manufacturing growth. Segment gross profit more than doubled to $65.5 million, and the company closed the quarter with a $2.36 billion backlog.

In September, Rocket Lab rolled out IMM Apex, a next-generation solar cell. According to the company, the product delivers 31.5% efficiency at beginning of life with 40% less mass than older germanium-based cells, and it is built to swap directly into existing spacecraft designs. Rocket Lab says more than 1,100 satellites already run on its solar products — a track record that forms part of the pitch for IMM Apex.

On the balance sheet, Rocket Lab's debt-to-capital ratio sits at 0.83%, far below the industry average of 61.13%. Its current ratio stands at 5.48, also well above the industry's 2.06.

The stock is not inexpensive by traditional valuation measures.LB trades at 35.25 times forward 12-month sales, compared with an industry average of 7.04 times.

Zacks currently rates Rocket Lab a #2 (Buy), citing improving earnings estimates alongside the stock's recent run. The consensus 2026 EPS estimate has risen 50% over the past 60 days.

Source: CoinCentral